Burkholderia cepacia Complex Lumbar Spondylodiscitis: A Rare Nosocomial Infection | Zendy

Rachel Subramanian | Zendy; Lynn Fitzgibbons | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Burkholderia cepacia Complex Lumbar Spondylodiscitis: A Rare Nosocomial Infection

Author(s) -

Rachel Subramanian,

Lynn Fitzgibbons

Publication year - 2022

Publication title -

case reports in infectious diseases

Language(s) - English

Resource type - Journals

eISSN - 2090-6625

pISSN - 2090-6633

DOI - 10.1155/2022/4378442

Subject(s) - medicine , cefepime , levofloxacin , spondylodiscitis , burkholderia cepacia complex , discitis , ciprofloxacin , burkholderia , gentamicin , ceftazidime , osteomyelitis , surgery , imipenem , antibiotics , microbiology and biotechnology , radiology , antibiotic resistance , magnetic resonance imaging , pseudomonas aeruginosa , genetics , bacteria , biology

Pyogenic spondylodiscitis is rarely caused by Burkholderia cepacia complex. B. cepacia is widespread in the environment and recognized as an opportunistic pathogen for patients with cystic fibrosis and immune disorders. A female in her mid-30s with underlying hyperthyroidism, but otherwise immunocompetent, was admitted to the hospital with persistent lower back pain after elective bariatric surgery in Mexico. Lumbar MRI showed L2/L3 osteomyelitis and discitis. Culture of disk aspiration grew Burkholderia cepacia complex sensitive to cefepime, ceftazidime, ciprofloxacin, gentamicin, imipenem, levofloxacin, and trimethoprim-sulfamethoxazole. The infection failed to respond to cefepime; however, she was successfully treated with levofloxacin monotherapy.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research